BLMH Antikörper (AA 212-242)
Kurzübersicht für BLMH Antikörper (AA 212-242) (ABIN7872198)
Target
Alle BLMH Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 212-242
-
Verwendungszweck
- Bleomycin hydrolase Antibody / BLMH
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- A portion of amino acids 212-242 from the human protein was used as the immunogen for the Bleomycin hydrolase antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting points. Titration of the Bleomycin hydrolase antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the Bleomycin hydrolase antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- BLMH (Bleomycin Hydrolase (BLMH))
-
Andere Bezeichnung
- Bleomycin hydrolase
-
Hintergrund
- The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B-aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity (By similarity).
-
UniProt
- Q13867
Target
-